2,683 results on '"Musto, Pellegrino"'
Search Results
152. IRF4 Gene Expression on the Trail of Molecular Response: Looking at Chronic Myeloid Leukemia from Another Perspective
153. High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma
154. Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile
155. Pyridine Controlled Tin Perovskite Crystallization
156. Diffuse Large B Cell Lymphoma Arising in Patients with Preexisting Hodgkin Lymphoma
157. Real‐life efficacy and safety of idelalisib in 55 double‐refractory follicular lymphoma patients
158. Comparison between azacitidine and decitabine as front-line therapy in elderly treatment naïve Acute Myeloid Leukemia not eligible for intensive chemotherapy
159. Survey on Adsorption of Low Molecular Weight Compounds in Cu-BTC Metal–Organic Framework: Experimental Results and Thermodynamic Modeling
160. Impact of severe acute respiratory syndrome coronavirus‐2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative Group
161. JAK2 V617f in chronic myeloid leukemia: driving force or passive bystander?
162. OAB-011: Predictors of unsustained negativity in minimal residual disease (MRD)-negative transplant-eligible newly diagnosed multiple myeloma (MM) patients enrolled in the FORTE trial
163. P-159: Effectiveness of anti-SARS-CoV-2 vaccine “booster” dose in patients with multiple myeloma
164. Rayleigh scattering by graphene-oxide in syndiotactic polystyrene aerogels
165. Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival
166. Diffusion in polymers as investigated by two-dimensional correlation spectroscopy: The H2O/PCL system
167. Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data
168. Methanol diffusion in polyimides: A molecular description
169. Absolute monocyte count at diagnosis could improve the prognostic role of early FDG‐PET in classical Hodgkin lymphoma patients
170. Leg Type Primary Cutaneous Diffuse Large B-Cell Lymphoma
171. Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program
172. Primary Plasma Cell Leukemia: Identity Card 2016
173. High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders
174. Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID‐19: The GIMEMA EMATO‐0321 study
175. Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials
176. FLT3 mutational analysis in acute myeloid leukemia: Advantages and pitfalls with different approaches
177. Plasma cell leukemia: another piece of the puzzle
178. Prospective, case-control study of serological response after two doses of BNT162b2 anti-SARS-CoV-2 mRNA vaccine in transfusion-dependent thalassemic patients
179. Clonal hematopoiesis in clinical practice: walking a tightrope
180. Structural feature of thermo-induced fluorochromism in a 1D zinc coordination polymer. A cross-analysis by PL and FTIR spectroscopy, and DFT formalism
181. Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials
182. Exploring the Potential of Eltrombopag: Room for More?
183. Engineering poly(ethylene oxide) buccal films with cyclodextrin: A novel role for an old excipient?
184. Aberrant activation of ROS1 represents a new molecular defect in chronic myelomonocytic leukemia
185. Confocal Raman imaging, FTIR spectroscopy and kinetic modelling of the zinc oxide/stearic acid reaction in a vulcanizing rubber
186. Italian Cytometry Society (GIC) endorsement of consensus recommendations for measurable residual disease in chronic lymphocytic leukemia
187. Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile
188. Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia
189. ITACA: A new validated international erythropoietic stimulating agent‐response score that further refines the predictive power of previous scoring systems
190. A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity‐score weighted multicenter approach
191. Lenalidomide and low‐dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials
192. Sorption of CO 2 , CH 4 and Their Mixtures in Amorphous Poly(2,6-dimethyl-1,4-phenylene)oxide (PPO).
193. RUNX1 gene alterations characterized by allelic preference in adult acute myeloid leukemia.
194. Overall and complication‐free survival in a large cohort of patients with β‐thalassemia major followed over 50 years.
195. Triamcinolone solubilization by (2-hydroxypropyl)-β-cyclodextrin: A spectroscopic and computational approach
196. Improving the photo-oxidative stability of epoxy resins by use of functional POSS additives: A spectroscopic, mechanical and morphological study
197. Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma
198. Primary plasma cell leukemia in the era of new drugs: Has something changed?
199. FISH analysis reveals frequent co-occurrence of 4q24/ TET2 and 5q and/or 7q deletions
200. Deciphering the effects of graft Tregs on chronic graft-versus-host disease: results from a prospective, multicenter study in patients with acute leukemia undergoing allogeneic peripheral blood stem cell transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.